brindle
CABRI Announces Undergraduate Fellowships and Scholarship Program
The Cayman Biomedical Research Institute (CABRI) is pleased to announce that applications for our undergraduate fellowships and scholarship program are open.
Undergraduate fellowships are available on a competitive basis to undergraduate students who have been offered an unpaid research position by a qualified principal investigator. Up to $5,000 per semester is available to each mentee-mentor team, with the entire amount paid as compensation to the undergraduate. The principal investigator will be responsible for the mentorship and guidance of the student during the period of the award.
“These fellowships are an excellent training opportunity for undergraduates to expand their knowledge outside the lecture hall,” said Kourtney Goode, Academic Relations Coordinator at Cayman Chemical. “Hands-on research is an equally valuable learning experience that introduces a student to a potential career path and fosters the growth of their talents.”
Undergraduate fellowship applications may be submitted on the CABRI website from August 22nd to September 18th, 2022, and awardees will be notified by October 16th, 2022.
As part of CABRI’s commitment to help college-bound students continue their education after losing a parent or guardian to sinonasal undifferentiated carcinoma (SNUC) or B-cell lymphoma, scholarships are available to support the continued education of these students.
Scholarship applications are accepted throughout the year and are available on the CABRI website.
CABRI is a nonprofit foundation that helps reduce the impact of rare diseases by funding research and supporting expanded opportunities for emerging scientists and families affected by these diseases. Contact CABRI with any questions about these funding opportunities.
CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods
The Cayman Biomedical Research Institute (CABRI) is pleased to announce a call for proposals that support essential research on specialized pro-resolving mediator (SPM) analytical methods.
There is a critical need for basic research on analytical methods used for specialized pro-resolving mediators (SPMs). SPMs are a family of lipid metabolites derived from polyunsaturated fatty acids (PUFAs) that promote the resolution of inflammation and have been detected in several experimental models and human conditions. However, researchers using mass spectrometry-based methods have been in conflict with each other, and do not agree on how much, if any, SPMs are present in biologically relevant contexts. Hence, continued research on SPM analytical methods is necessary for this field to move forward.
CABRI is offering research grants in amounts up to $100,000 to support this need. We encourage anyone seeking to provide clarity to SPM analytical methods to apply for these research grants.
Research proposal applications may be submitted on the CABRI website. These applications will be reviewed on a rolling basis.
CABRI is a nonprofit foundation that supports research on rare illnesses and orphan diseases. As part of CABRI’s commitment to the greater scientific community, CABRI awards research grants to academic scientists that address basic science research objectives with the highest unmet needs.
See some of CABRI’s past research grant recipients here.
Contact CABRI with any questions about this funding opportunity.
40 Women Researchers Receive $40,000 in Grants from Cayman and CABRI
Each year during Women’s History Month, Cayman provides travel grants to help women researchers attend conferences to benefit from and contribute to the larger scientific community. This year, because the COVID-19 pandemic caused most conferences to cancel or postpone and many academic labs to close, Cayman introduced a new program to help support women in research. This new program has doubled the grant amount to $1,000 for each recipient, designating the funds for use in research instead of travel. A record high of forty women will benefit from Cayman’s Women in Research program this year.
“We planned to award five well-qualified applicants,” said Dr. Kirk Maxey, President and CEO of Cayman. “But the applicant pool was so impressive, we extended the award to forty women who are working to answer essential research questions. Reviewing the value of the contributions these women are making to scientific discovery has made us optimistic for overcoming the many challenges facing human health and disease.”
2020 Women in Research Grant Recipients
- Adela Cota-Gomez, PhD, University of Colorado Anschutz Medical Campus, USA
- Ana-Maria Raicu, Michigan State University, USA
- Annelies Cannaert, PhD, Ghent University, Belgium
- Antonia Rotolo, MD, PhD, University of Pennsylvania, USA
- Aurélie de Rus Jacquet, PhD, Laval University, Canada
- Caitlyn Norman, University of Dundee, UK
- Carla Madelaire, PhD, Northern Arizona University, USA
- Carley Lowe, Northern Arizona University, USA
- Carmen De Miguel, PhD, University of Alabama at Birmingham, USA
- Chang Jiang, PhD, Moffitt Cancer Center, USA
- Christine Arbour, PhD, Massachusetts Institute of Technology, USA
- Diane McConnell, DVM, PhD, University of Missouri-Columbia, USA
- Eline Pottie, Ghent University, Belgium
- Elizabeth Delorme-Axford, PhD, Oakland University, USA
- Friederike Pohlin, PhD, University of Veterinary Medicine, Vienna
- Georgina Fabro, PhD, National University of Córdoba, Argentina
- Harriet Allan, PhD, Queen Mary University of London, UK
- Jennifer Speth, PhD, University of Michigan, USA
- Jiska van der Reest, PhD, Harvard Medical School, USA
- Kara Rood, MD, The Ohio State University Wexner Medical Center, USA
- Laila Ziko, PhD, American University in Cairo, Egypt
- Laura Torrente Fernandez, PhD, Moffitt Cancer Center, USA
- Luiza Oliveira Perucci, PhD, Federal University of Ouro Preto, Brazil
- Marcella Sharma, Wayne State University, USA
- Margaret Nolan, PhD, Stellenbosch University, South Africa
- Maria Fedorova, PhD, Leipzig University, Germany
- Marthe Vandeputte, Ghent University, Belgium
- Merran Dunford, University of Bath, UK
- Nerea Alonso, PhD, University of Edinburgh, UK
- Nona Ehyaei, Michigan State University, USA
- Paloma Gonzalez Sanchez, PhD, Moffitt Cancer Center, USA
- Renata Whitton, PhD, University of São Paulo, Brazil
- Samanta Funes, PhD, National University of San Luis, Argentina
- Shea Sickles, University of Kentucky, USA
- Stefanie U. Wetzels, PhD, University of Veterinary Medicine Vienna, Austria
- Stefanny Titon , PhD, University of São Paulo, Brazil
- Swati Venkat, PhD, Roswell Park Comprehensive Cancer Center, USA
- Swetha Gowrishankar, PhD, University of Illinois at Chicago, USA
- Tina Sumpter, PhD, University of Pittsburgh, USA
- Tinna Traustadóttir, PhD, Northern Arizona University, USA
Cayman worked with the Cayman Biomedical Research Institute (CABRI) to fund these extra awards. Cayman’s mission of helping make research possible fully aligns with the founding values of CABRI, which awards research grants to academic scientists and undergraduate students to support their pursuit of new therapeutic approaches against diseases of highest unmet need as well as scholarships to college-bound students who have lost a parent to a rare disease. To further support the research of these grant winners, Cayman will provide 20% off their catalog orders for the entirety of 2021. The work of these recipients will be highlighted over the months to come through Cayman’s social media outlets.
About CABRI
Cayman Biomedical Research Institute (CABRI) is a nonprofit organization which supports research on the rare illnesses and orphan diseases that are often neglected by the corporate pharmaceutical industry and actively pursues new developments that will treat these diseases. To support this endeavor, we offer research grants to specific principal investigators at academic research institutions who have a plan to extend the clinical or pre-clinical development for these diseases as well as undergraduate grants to assist students to obtain experience in laboratories while performing research that aligns with CABRI’s mission. CABRI also provides scholarships to college-bound students who have lost a parent to SNUC (sinonasal undifferentiated carcinoma).
About Cayman Chemical
Cayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination. In addition, we offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic